新着情報
2023-03-31
弊社研究員の安藤(千葉大学医学部附属病院企画情報部客員研究員兼務)が実施する研究が、リウマチ分野の学術誌 Modern Rheumatologyに掲載されました。
Seasonal exacerbation of rheumatoid arthritis detected by big claims data analysis: A retrospective population study
Fumihiko Ando and others
Modern Rheumatology, Volume 33, Issue 1, January 2023, Pages 46–53, https://doi.org/10.1093/mr/roab122
Published: 15 February 2022
Seasonal exacerbation of rheumatoid arthritis detected by big claims data analysis: A retrospective population study
Fumihiko Ando and others
Modern Rheumatology, Volume 33, Issue 1, January 2023, Pages 46–53, https://doi.org/10.1093/mr/roab122
Published: 15 February 2022
2023-02-10
弊社研究員(安藤文彦:千葉大学医学部附属病院 企画情報部 客員研究員兼務)が、株式会社NTTデータ数理システム様主催のアカデミックコンファレンスにて、NDBデータの臨床研究への活用~リウマチ領域を例に~との演題で講演を行いました。
2022-10-31
弊社研究の安藤(千葉大学医学部附属病院企画情報部客員研究員兼務)が支援する研究が、リウマチ分野の学術誌 Modern Rheumatologyに掲載されました。
Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study
Katsuhiko Takabayashi and others
Modern Rheumatology, roac133, https://doi.org/10.1093/mr/roac133
Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study
Katsuhiko Takabayashi and others
Modern Rheumatology, roac133, https://doi.org/10.1093/mr/roac133
2022-04-07
弊社研究員(安藤)がデータの分析を支援する研究が学術誌に掲載されました。
Trend in Prescription and Treatment Retention of Molecular-Targeted Drugs in 121,131 Japanese Patients With Rheumatoid Arthritis: A Population-Based Real-World Study
Katsuhiko Takabayashi and Fumihiko Ando and Kei Ikeda and Shinsuke Fujita and Hiroshi Nakajima and Hideki Hanaoka and Takahiro Suzuki
Modern Rheumatology(in press), DOI: 10.1093/mr/roab126
Trend in Prescription and Treatment Retention of Molecular-Targeted Drugs in 121,131 Japanese Patients With Rheumatoid Arthritis: A Population-Based Real-World Study
Katsuhiko Takabayashi and Fumihiko Ando and Kei Ikeda and Shinsuke Fujita and Hiroshi Nakajima and Hideki Hanaoka and Takahiro Suzuki
Modern Rheumatology(in press), DOI: 10.1093/mr/roab126